Weill Cornell Medicine Ophthalmology is one of only eleven sites in the United States which offers BostonSight® PROSE (prosthetic replacement of the ocular surface ecosystem) in collaboration with Boston Foundation for Sight. BostonSight® PROSE is a treatment to restore the vision of patients with complex corneal disease, enabling them to reclaim their lives. During PROSE treatment, physicians design, customize, and fit prosthetic devices to replace or support damaged ocular functions by improving vision and reducing pain and light sensitivity. PROSE can be the ideal, and sometimes only, treatment capable of restoring vision and dramatically reducing symptoms such as eye pain, severe dry eye, blurry vision and light sensitivity.
Benefits of PROSE treatment:
Reduces symptoms and supports healing by restoring a healthy ocular surface environment
Improves blurry vision by masking surface corneal irregularities and transmitting a sharp image to the back of the eye
Prevents damage by protecting the cornea against the environment and eyelids
Together with our partners, we have successfully treated thousands of patients with conditions such as:
Our PROSE clinic opened in 2010 under the direction of PROSE Clinical Fellow Michelle Lee, OD. Today, Jessica Ciralsky, MD, and Michelle Lee, OD work together to help treat and care for PROSE patients.
Why choose Weill Cornell Medicine Ophthalmology
Weill Cornell Medicine Ophthalmology is comprised of internationally acclaimed board certified & fellowship trained providers with extensive ophthalmic experience and documented academic excellence. In addition to practicing in a state-of-the art facility with the most current technologies, we are proud to offer our patients the best possible medical care and a variety of ophthalmic services.
Our friendly staff is happy to assist you with any questions you may have regarding candidacy, billing, insurance or scheduling. It is our goal to make the approval and treatment process as easy as possible for our patients.